SCHEMBL21115446

SCHEMBL21115446

CC(C)Cc1ccc2nc(-c3ccccc3)sc2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.57
SMN1; SMN2 Q16637 5/20 0.57
MAPT P10636 5/20 0.57
HPGD P15428 4/20 0.57
GLA P06280 3/20 0.57
GAA P10253 3/20 0.57
PKM P14618 3/20 0.57
ALDH1A1 P00352 2/20 0.57
MEN1 O00255 1/20 0.57
KMT2A Q03164 1/20 0.57
NFKB1 P19838 3/20 0.55
NFKB2 Q00653 3/20 0.55
RELA Q04206 3/20 0.55
LMNA P02545 1/20 0.55
APP P05067 9/20 0.49
RAB9A P51151 5/20 0.49
PAX8 Q06710 1/20 0.49
NOD2 Q9HC29 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
NPC1 O15118 4/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24906049 0.88 KDM4E (0.62) KDM4ESMN1; SMN2MAPTHPGDGLA
SCHEMBL23954311 0.88 KDM4E (0.51) KDM4ESMN1; SMN2MAPTHPGDGLA
SCHEMBL12967444 0.83 SMN1; SMN2 (0.62) KDM4ESMN1; SMN2MAPTHPGDGLA
SCHEMBL28265561 0.81 SMN1; SMN2 (0.59) KDM4ESMN1; SMN2MAPTHPGDGLA
SCHEMBL506665 0.80 KDM4E (0.62) KDM4ESMN1; SMN2MAPTHPGDGLA
SCHEMBL507537 0.80 KDM4E (0.67) KDM4ESMN1; SMN2MAPTHPGDGLA
SCHEMBL12596887 0.80 APP (0.68) KDM4ESMN1; SMN2MAPTHPGDGLA
SCHEMBL10230259 0.80 KDM4E (0.62) KDM4ESMN1; SMN2MAPTHPGDGLA
SCHEMBL12596888 0.80 KDM4E (0.62) KDM4ESMN1; SMN2MAPTHPGDGLA
SCHEMBL22455579 0.80 HPGD (0.43) KDM4ESMN1; SMN2MAPTHPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190198769-A1 COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2019-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190198769-A1 COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME OR10J3, ODC1, ETV6 KDM4E 961/4885SMN1; SMN2 2466/4885MAPT 2835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.